← Evidence library

BIB_417

Physical activity & survival in melanoma survivors — convergent 2025-26 evidence that the exercise mortality benefit in melanoma patients operates PRIMARILY through the competing-risk (non-melanoma/all-cause) pathway, NOT through melanoma-specific recurrence reduction. NOWAC prospective cohort (n=1,829): pre-diagnosis PA was non-significantly associated with melanoma-specific mortality (HR 0.69; CI crosses 1.0) but SIGNIFICANTLY reduced other-cause + all-cause mortality. Picelli 2026 JEADV meta-analysis (7 studies, melanoma + NMSC): post-diagnosis PA associated with reduced all-cause mortality…

Evidence grade

B

Tier

1 (Picelli: JEADV peer-reviewed systematic review/meta-analysis, 7 studies; Perr

Cited by tasks

11, 21, 25, 26

Identifiers

PMC8576825 · DOI:10.1111/jdv · PMID:40181554

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_417/findings.md (research corpus). This page is a short context summary — not individualised medical advice.